Hospital San Juan de Alicante
Alicante, Spain
University hospital in Spain
N-332, s/n, 03550 Sant Joan d'Alacant, Alicante
About Hospital San Juan de Alicante
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kowa Research Europe
4
Hospital Arnau de Vilanova
3
Pfizer
3
Fundación EPIC
2
Universidad Miguel Hernandez de Elche
2
Acist Medical Systems
1
Biosensors Europe SA
1
Boehringer Ingelheim
1
Clinical Trial Agency of HIV Study Group
1
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
1
Clinical Trials at Hospital San Juan de Alicante
During the past decade, Hospital San Juan de Alicante conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 7 clinical trials were completed, i.e. on
average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention
2004-09-01
2005-10-01
Completed
947
Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels
2005-10-01
2006-11-01
Completed
830
Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
2004-06-01
2006-11-01
Completed
360
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
355
Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia
2006-07-01
2007-11-01
Completed
1,355
Follow-on Protocol of Pitavastatin Versus Simvastatin in Patients With Hypercholesterolemia or Dyslipidemia and Coronary Heart Disease Risk Factors
2006-06-01
2007-08-01
Completed
178
Biweekly Gemcitabine and Docetaxel as First Line Treatment for Advanced Disease in Elderly Non-Small Cell Lung Cancer (NSCLC) Patients
2007-10-01
2011-09-01
Unknown status
48
Biweekly Gemcitabine and Docetaxel as First Line Therapy for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
2007-10-01
2011-10-01
Unknown status
76
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital San Juan de Alicante" #1 sponsor was "Kowa Research Europe" with 4 trials, followed by "Hospital Arnau de Vilanova" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Fundación EPIC" with 2 trials sponsored and "Universidad Miguel Hernandez de Elche"
with 2 trials sponsored. Other sponsors include 15 different institutions and
companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital San Juan de Alicante"
#1 collaborator was "Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Hospital Universitario San Juan de Alicante" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Hospital San Juan de Alicante
According to Clinical.Site data, the most researched conditions in "Hospital San Juan de Alicante" are
"Coronary Artery Disease" (6 trials), "Dyslipidemia" (4 trials), "Atrial Fibrillation" (3 trials), "Hypercholesterolemia" (3 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Hospital San Juan de Alicante" in a lesser frequency.
Clinical Trials Intervention Types at Hospital San Juan de Alicante
Most popular intervention types in "Hospital San Juan de Alicante" are "Drug" (17 trials), "Device" (4 trials), "Other" (4 trials), "Diagnostic Test" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Gemcitabine and Docetaxel" (2 trials), "Pitavastatin" (2 trials), "Placebo" (2 trials), "pitavastatin" (2 trials) and "simvastatin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital San Juan de Alicante
The vast majority of trials in "Hospital San Juan de Alicante" are
32 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hospital San Juan de Alicante
Currently, there are NaN active trials in "Hospital San Juan de Alicante".
undefined are not yet recruiting,
5 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Hospital San Juan de Alicante,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital San Juan de Alicante, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 2 trials that are defined as “Not Applicable".